TrialIntegrative cancer therapies2018

A Controlled Trial of Sheng-Yu-Tang for Post-Hematopoietic Stem Cell Transplantation Leukemia Patients: A Proposed Protocol and Insights From a Preliminary Pilot Study.

Tom Fleischer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.